Literature DB >> 10455134

AML1 (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter.

T A Libermann1, Z Pan, Y Akbarali, C J Hetherington, J Boltax, D A Yergeau, D E Zhang.   

Abstract

AML1 plays a critical role during hematopoiesis and chromosomal translocations involving AML1 are commonly associated with different forms of leukemia, including pre-B acute lymphoblastic leukemia. To understand the function of AML1 during B cell differentiation, we analyzed regulatory regions of B cell-specific genes for potential AML1-binding sites and have identified a putative AML1-binding site in the promoter of the B cell-specific tyrosine kinase gene, blk. Gel mobility shift assays and transient transfection assays demonstrate that AML1 binds specifically to this site in the blk promoter and this binding site is important for blk promoter activity. Furthermore, in vitro binding analysis revealed that the AML1 runt DNA-binding domain physically interacts with the paired DNA-binding domain of BSAP, a B cell-specific transcription factor. BSAP has been shown previously to be important for B cell-specific regulation of the blk gene. Physical interaction of AML1 with BSAP correlates with functional cooperativity in transfection studies where AML1 and BSAP synergistically activate blk promoter transcription by more than 50-fold. These results demonstrate physical and functional interactions between AML1 and BSAP and suggest that AML1 is an important factor for regulating a critical B cell-specific gene, blk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455134     DOI: 10.1074/jbc.274.35.24671

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2.

Authors:  Wei Wang; Sven Schwemmers; Elizabeth O Hexner; Heike L Pahl
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

3.  New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.

Authors:  Jian Li; Chun Guo; Nickolas Steinauer; Jinsong Zhang
Journal:  Front Biol (Beijing)       Date:  2016-09-03

4.  B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22).

Authors:  Guangsheng He; Depei Wu; Aining Sun; Yongquan Xue; Zhengming Jin; Huiying Qiu; Xiaowen Tang; Miao Miao; Zhengzheng Fu; Xiao Ma; Xiuli Wang; Zixin Chen; Changgeng Ruan
Journal:  Int J Hematol       Date:  2008-02-22       Impact factor: 2.490

5.  SERPINB13 is a novel RUNX1 target gene.

Authors:  Anita Boyapati; Bing Ren; Dong-Er Zhang
Journal:  Biochem Biophys Res Commun       Date:  2011-06-23       Impact factor: 3.575

6.  The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3.

Authors:  Luke F Peterson; Anita Boyapati; Velvizhi Ranganathan; Atsushi Iwama; Daniel G Tenen; Schickwann Tsai; Dong-Er Zhang
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

7.  Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype.

Authors:  Lindsay C Spender; Georgina H Cornish; Alexandra Sullivan; Paul J Farrell
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Cbfbeta-SMMHC impairs differentiation of common lymphoid progenitors and reveals an essential role for RUNX in early B-cell development.

Authors:  Ya-Huei Kuo; Rachel M Gerstein; Lucio H Castilla
Journal:  Blood       Date:  2007-10-16       Impact factor: 22.113

Review 9.  RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.

Authors:  Kentson Lam; Dong-Er Zhang
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

10.  Hmga2 is a direct target gene of RUNX1 and regulates expansion of myeloid progenitors in mice.

Authors:  Kentson Lam; Alexander Muselman; Randal Du; Yuka Harada; Amanda G Scholl; Ming Yan; Shinobu Matsuura; Stephanie Weng; Hironori Harada; Dong-Er Zhang
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.